KTRA Company Profile and Key Details
Kintara Therapeutics, Inc.
KTRA Stock Price Chart
Stock Price Today
Kintara Therapeutics, Inc. (KTRA) stock declined over -6.31%, trading at $0.22 on NASDAQ, down from the previous close of $0.23. The stock opened at $0.24, fluctuating between $0.20 and $0.24 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a photodynamic therapy for the treatment of cutaneous metastatic breast cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.
Company Information
| Employees | 1 |
| Beta | 0.81 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | June |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Kintara Therapeutics, Inc. (NASDAQ: KTRA) stock price is $0.22 in the last trading session. During the trading session, KTRA stock reached the peak price of $0.24 while $0.20 was the lowest point it dropped to. The percentage change in KTRA stock occurred in the recent session was -6.31% while the dollar amount for the price change in KTRA stock was -$0.01.
The NASDAQ listed KTRA is part of Biotechnology industry that operates in the broader Healthcare sector. Kintara Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Greg A. Johnson
Acting Head of Operations
Mr. Robert E. Hoffman B.B.A., C.P.A., CPA
Pres, Chief Executive Officer, Chief Financial Officer & Chairman
Mr. Robert E. Hoffman B.B.A., CPA, CPA
Pres, Chief Executive Officer, Chief Financial Officer & Chairman
Mr. Jeffrey A. Bacha B.Sc., M.B.A.
Founder
Mr. Scott Praill B.Sc., C.P.A., CA, CPA, BSc
Chief Financial Officer & Sec.
Mr. Scott Praill B.Sc., BSc, C.P.A., CA, CPA
Chief Financial Officer & Sec.
KTRA's closing price is 5.12% higher than its 52-week low of $0.20 where as its distance from 52-week high of $26.21 is -99.18%.
Number of KTRA employees currently stands at 1.
Official Website of KTRA is: https://www.kintara.com
KTRA could be contacted at phone 858 350 4364 and can also be accessed through its website. KTRA operates from 12707 High Bluff Drive, San Diego, CA 92130, United States.
KTRA stock volume for the day was 3.55M shares. The average number of KTRA shares traded daily for last 3 months was 83.39K.
The market value of KTRA currently stands at $11.99M with its latest stock price at $0.22 and 55.66M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com